Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
11:30am, Tuesday, 09'th Aug 2022 Benzinga
Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading.
Needham lowered the price target
Why Aurinia Pharmaceuticals Stock Briefly Spiked Today
03:58pm, Thursday, 04'th Aug 2022 The Motley Fool
Investors embraced the biotech's second-quarter results.
Aurinia Pharmaceuticals Inc's (AUPH) CEO Peter Greenleaf on Q2 2022 Results - Earnings Call Transcript
12:02pm, Thursday, 04'th Aug 2022
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants DeDe Sheel – Vice President-Investor Relations Peter Greenleaf – Preside
Why Aurinia Pharmaceuticals Stock Briefly Spiked Today
11:58am, Thursday, 04'th Aug 2022
Investors embraced the biotech's second-quarter results.
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
11:35am, Thursday, 04'th Aug 2022 Zacks Investment Research
Aurinia (AUPH) delivered earnings and revenue surprises of -13.64% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
09:02am, Thursday, 04'th Aug 2022
Aurinia (AUPH) delivered earnings and revenue surprises of -13.64% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Aurinia Pharmaceuticals Stock Is Sliding Today
04:22pm, Wednesday, 27'th Jul 2022 The Motley Fool
An analyst downgraded the stock.
Why Aurinia Pharmaceuticals Stock Is Sliding Today
12:22pm, Wednesday, 27'th Jul 2022
An analyst downgraded the stock.
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
09:29am, Wednesday, 27'th Jul 2022 Benzinga
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Pag
Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022
04:07pm, Monday, 25'th Jul 2022
VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that it will release financial and operat
Why Bank Stocks Traded Sharply Higher; Here Are 65 Biggest Movers From Friday
09:43am, Monday, 18'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offer
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
04:11pm, Friday, 15'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Ce
Why Aurinia Pharmaceuticals Stock Is In Retreat Today
04:01pm, Friday, 15'th Jul 2022 The Motley Fool
Investors are none too pleased with the company's recent slew of hires.
Why Aurinia Pharmaceuticals Stock Is In Retreat Today
12:01pm, Friday, 15'th Jul 2022
Investors are none too pleased with the company's recent slew of hires.
Aurinia (AUPH) Moves 13.3% Higher: Will This Strength Last?
07:17am, Tuesday, 05'th Jul 2022 Zacks Investment Research
Aurinia (AUPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
